Popular Trials
Nutrition and Exercise for Acute Lymphoblastic Leukemia
Recruiting1 award2 criteria
Chicago, Illinois
This trial will investigate how diet and exercise impact muscle and body fat in adults with a certain type of blood cancer. Participants will be split into two groups: one focusing on nutrition and the other on exercise
Behavioral Intervention
EMPOWER Strategy for HIV Prevention
Recruiting1 award5 criteria
Chicago, Illinois
This trial aims to help cisgender women make informed decisions about taking PrEP to prevent HIV. Researchers will use technology to send educational materials in English or Spanish through electronic health records and help schedule PrEP
Myopia Control
DG1 Spectacle Lens for Near-sightedness
Recruiting0 awards1 criteria
Chicago, Illinois
This trial aims to test the safety and effectiveness of a special DG1 lens for controlling myopia progression in children. They will compare this DG1 lens with regular single-vision spectacles to see if
Behavioural Intervention
Ultrasound + Education for Heart Failure
Recruiting0 awards2 criteria
Chicago, Illinois
This trial aims to see if using point-of-care ultrasound (POCUS) can help adults at risk for heart failure to better understand their condition and improve their lifestyle habits. Participants will either receive educational intervention
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Rilvegostomig Combination for Stomach Cancer
Recruiting2 awardsPhase 3
Chicago, Illinois
"This trial is studying the effectiveness and safety of a new drug called rilvegostomig in combination with other medications for treating a specific type of stomach cancer. They will compare this new combination
Corticosteroid
Baxdrostat + Dapagliflozin for Chronic Kidney Disease and High Blood Pressure
Recruiting1 awardPhase 3
Rockford, Illinois
This trial will test a new medication called Baxdrostat with Dapagliflozin to see if it can improve kidney health and reduce the risk of heart problems in people with chronic kidney
Trials With No Placebo
Radiation
Total Marrow Irradiation for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Chicago, Illinois
This trial will test a treatment for patients undergoing stem cell transplant. Patients will first receive radiation therapy followed by chemotherapy to prepare their body for the transplant. They will also receive medications to prevent complications after the
Behavioural Intervention
SUPPORT Workbook for Urinary Incontinence
Recruiting1 award1 criteria
Chicago, Illinois
This trial aims to create a program called SUPPORT to help racially minoritized women with urinary incontinence and lower urinary tract symptoms. The program combines various evidence-based treatments like cognitive behavioral therapy and physical therapy
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.